{Reference Type}: Journal Article
{Title}: Comparison of laser and traditional lancing devices for capillary blood sampling in patients with diabetes mellitus and high bleeding risk.
{Author}: Park MJ;Hwang SY;Jang A;Jang SY;Song E;Park SY;Lee DY;Kim J;Park BC;Yu JH;Seo JA;Choi KM;Baik SH;Yoo HJ;Kim NH;
{Journal}: Lasers Med Sci
{Volume}: 39
{Issue}: 1
{Year}: 2024 Jul 3
{Factor}: 2.555
{DOI}: 10.1007/s10103-024-04128-6
{Abstract}: <B>OBJECTIVE: </B>Despite the importance of self-monitoring blood glucose (SMBG) for management of diabetes mellitus (DM), frequent blood sampling is discouraged by bleeding risk due to dual-antiplatelet agent therapy (DAPT) or thrombocytopenia.<BR><B>METHODS: </B>We compared the bleeding time (BT) of sampling by using a laser-lancing-device (LMT-1000) and a conventional lancet in patients with DM and thrombocytopenia or patients undergoing DAPT. BT was measured using the Duke method, and pain and satisfaction scores were assessed using numeric rating scale (NRS) and visual analog scale (VAS). The consistency in the values of glucose and glycated-hemoglobin (HbA1c) sampled using the LMT-1000 or lancet were compared.<BR><B>RESULTS: </B>The BT of sampling with the LMT-1000 was shorter than that with the lancet in patients with thrombocytopenia (60s vs. 85s, P = 0.024). The NRS was lower and the VAS was higher in laser-applied-sampling than lancet-applied sampling in the DAPT-user group (NRS: 1 vs. 2, P = 0.010; VAS: 7 vs. 6, P = 0.003), whereas the group with thrombocytopenia only showed improvement in the VAS score (8 vs. 7, P = 0.049). Glucose and HbA1c sampled by the LMT-1000 and lancet were significantly correlated in both the DAPT-user and the thrombocytopenia groups.<BR><B>CONCLUSIONS: </B>The LMT-1000 can promote SMBG by shortening BT in subject with thrombocytopenia and by increasing satisfaction score, as well as by showing reliable glucose and HbA1c value.